ARTICLE | Company News
XOMA Corp. news
January 3, 1995 8:00 AM UTC
The Berkeley, Calif., company discontinued development of its CD Plus product to treat in vivo acute graft-versus-host disease, based on low projected economic returns and assessment of data from its ...